Skip to main content

Table 4 Clinical response of the 13 patients with increased ANA titer after IFX

From: Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study

 

ANA titer

EULAR response

 

Before

After

 

1

< 40

80

Good

2

< 40

80

No

3

< 40

640

No

4

< 40

640

No

5

40

160

No

6

40

160

No

7

40

160

Moderate

8

40

320

No

9

40

320

No

10

40

1,280

No

11

80

640

Moderate

12

160

640

No

13

320

1,280

No

  1. ANAs, antinuclear antibodies; IFX, infliximab.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us